vorinostat has been researched along with Abnormalities, Autosome in 1 studies
Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Vorinostat was approved as the first histone deacetylase inhibitor for the management of cutaneous T cell lymphoma." | 1.56 | Vorinostat is genotoxic and epigenotoxic in the mouse bone marrow cells at the human equivalent doses. ( Ahmad, SF; Al-Hamamah, MA; Al-Khalifa, MK; Alotaibi, MR; Ansari, MA; Attia, MSM; Attia, SM; Bakheet, SA; Nadeem, A, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Attia, SM | 1 |
| Al-Khalifa, MK | 1 |
| Al-Hamamah, MA | 1 |
| Alotaibi, MR | 1 |
| Attia, MSM | 1 |
| Ahmad, SF | 1 |
| Ansari, MA | 1 |
| Nadeem, A | 1 |
| Bakheet, SA | 1 |
1 other study available for vorinostat and Abnormalities, Autosome
| Article | Year |
|---|---|
Vorinostat is genotoxic and epigenotoxic in the mouse bone marrow cells at the human equivalent doses.
Topics: Animals; Antineoplastic Agents; Apoptosis; Bone Marrow Cells; Chromosome Aberrations; Comet Assay; D | 2020 |